NCT00280501View on ClinicalTrials.gov

Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Regional Blood FlowOcular Physiology
Interventions
DRUG

Quetiapine (drug)

Quetiapine (Seroquel 100mg-film-coated tablet, AstraZeneca Vienna, Austria) Dose: 100 mg tablet oral single dose

DRUG

Sulpiride (drug)

Sulpiride (Dogmatil 200mg-tablet, Synthélabo Groupe, Le Plessis Robinson, France) Dose: one half of 200 mg tablet oral single dose

DRUG

Placebo

Placebo

Trial Locations (1)

1090

Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00280501 - Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions | Biotech Hunter | Biotech Hunter